You are here: All Products  > Akeso Completes Phase III Trial Enrollment of PD-1/VEGF Bispecific for NSCLC

Akeso Completes Phase III Trial Enrollment of PD-1/VEGF Bispecific for NSCLC

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products